Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/4f/10/62/4f1062ef-66c3-a0fa-e529-316c138639f1/mza_6497164257034567976.jpg/600x600bb.jpg
Breaking Protocol
Tilda
5 episodes
4 days ago
The clinical trial industry is stuck in an innovation impasse, weighed down by outdated processes, layers of bureaucracy, and a systemic inability to prioritize those on the frontlines - patients, sites, and researchers. Tune in every week as Tilda Research CEO Ram Yalamanchili interviews clinical trial leaders at the cutting edge of innovation who are breaking past the current paradigm.
Show more...
Life Sciences
Science
RSS
All content for Breaking Protocol is the property of Tilda and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The clinical trial industry is stuck in an innovation impasse, weighed down by outdated processes, layers of bureaucracy, and a systemic inability to prioritize those on the frontlines - patients, sites, and researchers. Tune in every week as Tilda Research CEO Ram Yalamanchili interviews clinical trial leaders at the cutting edge of innovation who are breaking past the current paradigm.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43670737/43670737-1747239163791-0989f8fe827aa.jpg
Dr. David Chin Yee: Streamlining Clinical Trials
Breaking Protocol
34 minutes 38 seconds
5 months ago
Dr. David Chin Yee: Streamlining Clinical Trials

Transforming Clinical Trials with AI: An in-depth Discussion with Dr. David Chin YeeDr. David Chin Yee, Research Director at Georgia Retina shares his journey and the transformation of the practice with the use of AI teammates. Georgia Retina is one of the largest private practice retina groups in the Southeast. As an early adopter of AI to streamline clinical research, he discusses the integration of AI into his studies, how he's dealing with challenges of high staff turnover, and the critical role of efficient systems in improving clinical research outcomes. Learn about the future of AI in ophthalmology and the steps Dr. Chin Yee is taking to make Georgia Retina a top-tier clinical trial site.

Breaking Protocol
The clinical trial industry is stuck in an innovation impasse, weighed down by outdated processes, layers of bureaucracy, and a systemic inability to prioritize those on the frontlines - patients, sites, and researchers. Tune in every week as Tilda Research CEO Ram Yalamanchili interviews clinical trial leaders at the cutting edge of innovation who are breaking past the current paradigm.